GlassScriptPhysician profile
Stanley K Chou
NPI 1194722611
$4,993.07
in general payments reported to CMS, 2019-2025
32 companies · $49.12 in 2025
The $49.12 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,226 · 2020: $797 · 2021: $661 · 2022: $334 · 2023: $479 · 2024: $446 · 2025: $49.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,592.73 | 2019-2020 | |
| Medtronic, INC. | $1,047.47 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Daiichi Sankyo INC. | $438.57 | 2019 | |
| Scilex Pharmaceuticals INC. | $307.96 | 2019-2024 | |
| Abbott Laboratories | $221.13 | 2019-2023 | Proclaim |
| Nevro Corp. | $148.46 | 2019-2020 | |
| Boston Scientific Corporation | $144.24 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Zynex Medical, INC. | $135.96 | 2023 | Nexwave |
| Biodelivery Sciences International, INC. | $94.70 | 2020-2021 | |
| Heron Therapeutics, INC. | $89.85 | 2021 | |
| West Therapeutics Development, LLC | $85.31 | 2019-2020 | |
| Redhill Biopharma INC. | $75.33 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.49 | 2020-2022 | |
| Tersera Therapeutics LLC | $65.99 | 2024 | Prialt |
| Horizon Therapeutics Plc | $60.17 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $43.83 | 2019 | |
| Arbor Pharmaceuticals, INC. | $39.36 | 2019-2020 | |
| Trevena, INC. | $34.60 | 2021 | |
| Micromed INC | $32.90 | 2021 | |
| Vanda Pharmaceuticals INC. | $32.44 | 2020 | |
| Zyla Life Sciences, INC. | $29.59 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $27.74 | 2022-2023 | Seglentis |
| Azurity Pharmaceuticals, INC. | $23.37 | 2024 | Horizant |
| Biotissue Holdings INC. | $21.96 | 2024 | |
| Valinor Pharma, LLC | $21.32 | 2023 | Movantik |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.57 | 2019 | |
| Averitas Pharma INC. | $18.63 | 2023 | Qutenza |
| Ibsa Pharma INC. | $17.62 | 2023 | Tirosint, Licart |
| Pfizer INC. | $15.78 | 2019 | |
| Avanos Medical | $13.17 | 2019 | |
| Almatica Pharma LLC | $12.49 | 2021 | |
| Spr Therapeutics, INC | $10.34 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.